Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate
NCT03569345
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Carcinoma, Basal Cell
Interventions
DRUG:
AFXl-assisted ingenol mebutate delivery
Sponsor
Merete Haedersdal
Collaborators
[object Object]